These findings demonstrate that PACS‐2 supports NPSC‐mediated IVD regeneration by maintaining MAM integrity via the SP1/LRRK2/Mfn2 axis, offering potential therapeutic targets for IDD. Here, LRRK2 is linked to intervertebral disk degenerative disorder.